- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04074954
A (Prospective/Pilot) Study Evaluating the Effect of Cataract Surgery on the Daily Activity Levels of Elderly Patients
November 29, 2023 updated by: University of Pikeville
To evaluate the effect of bilateral cataract surgery with intraocular lens implantation on the daily activity levels of elderly patients.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Cataract formation is a natural aging process that can be influenced by environmental factors such as exposure to ultra violet light and diet.
Additionally, metabolic disorders, such as diabetes can lead to an earlier development of cataracts.
As cataracts develop, a patient's vision can be affected.
Reduced vision can limit activities of daily living and may even reduce a patient's mobility.
When this occurs, cataract surgery should be considered to help restore a patient's vision.
With the obesity and diabetic epidemic, proper diet and exercise is a major health initiative to control these diseases.
If a patient's mobility is reduced as a result of poor vision - their ability to achieve adequate daily physical activity may also be effected.
It is thought that improvement in vision may increase their activity levels and help combat these health issues.
This study will investigate the activity level of patients before and after undergoing cataract surgery to determine how improved vision quality from removal of the natural lens inside the eye and replacement with an artificial intraocular lens effects their activity level.
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40223
- Bennett and Bloom Eye Centers
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Adult patients undergoing bilateral cataract surgery and adult patients who have cataracts but are not undergoing cataract.
Consecutive patients based on the inclusion criteria will be selected for the study.
Description
Inclusion Criteria:
- Patients undergoing bilateral cataract extraction by phacoemulisficatin with intraocular lens implantation and a planned bilateral distance vision target or patients with bilateral cataracts who are not having cataract surgery
- Patients aged 60 years old or older
- Best corrected visual acuity worse than 20/20 in each eye (meaning 20/25 or worse)
- Non-comanged patients
Exclusion Criteria:
- Greater than 0.76 D pre-operative corneal cylinder, if having cataract surgery without a planned astigmatism correction (I.e Limbal relaxing incision or Toric intraocular lens)
- Planned implantation of a multifocal intraocular lens
- Visual field defect which may reduce mobility
- Wheel chair bound patients
- Reduced vision from an ocular disease other than cataracts
- Patients with significant dementia who are not able to fully comprehend the informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Cataracts present, no surgery
Adult patients undergoing bilateral cataract surgery
|
|
|
Cataracts present, yes surgery
adult patients who have cataracts but are not undergoing cataract surgery
|
Patients will receive cataract surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amount of activity conducted by the patient before receiving surgery
Time Frame: 10 days prior to surgery
|
Measured by a wrist activity tracker
|
10 days prior to surgery
|
|
Amount of activity conducted by the patient after receiving surgery
Time Frame: 10 days after surgery
|
Measured by a wrist activity tracker
|
10 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kelley E Sedlock, OD, University of Pikeville
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 23, 2023
Primary Completion (Estimated)
July 31, 2023
Study Completion (Estimated)
July 31, 2023
Study Registration Dates
First Submitted
August 22, 2019
First Submitted That Met QC Criteria
August 27, 2019
First Posted (Actual)
August 30, 2019
Study Record Updates
Last Update Posted (Estimated)
December 6, 2023
Last Update Submitted That Met QC Criteria
November 29, 2023
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CataractStudy1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Cataract surgery
-
Zagazig UniversityCompleted
-
Iladevi Cataract and IOL Research CenterCompletedCataract Surgery | Shallow Anterior Chamber | PhacoemulsificationIndia
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
University of OklahomaCompletedPrimary Open Angle Glaucoma | Cataract | Pigmentary GlaucomaUnited States
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
Medical University of GrazRecruiting
-
Ziemer Ophthalmic Systems AGCompleted
-
Technolas Perfect Vision GmbHCompleted
-
Glaukos CorporationCompletedOpen-Angle GlaucomaUnited States
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingCataract | Cataract Bilateral | Cataract Surgery